Effectiveness of autologous haematopoietic stem cell transplantation versus natalizumab in progressive multiple sclerosis.
Tomas KalincikSifat SharminIzanne RoosJennifer MasseyIan SuttonBarbara WithersMark S FreedmanHarold AtkinsEva KrasulovaEva Kubala HavrdovaMarek TrnenyTomas KozakJoachim BurmanRichard MacdonellØivind TorkildsenLars BøAnne Kristine LehmannBasil SharrackJohn SnowdenPublished in: Journal of neurology, neurosurgery, and psychiatry (2024)
This study does not support the use of AHSCT to control disability in progressive MS with advanced disability and low relapse activity.